TYLER POPIL: Open Payments
NPI 1235638263 · WILLOUGHBY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 41 payments from 14 companies in 2025. Trend: 2023 $37 · 2024 $788 · 2025 $738
Food & beverage: $738
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $320 |
| Astellas Pharma US Inc | 8 | $167 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $33 |
| Corcept Therapeutics | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| SANOFI-AVENTIS U.S. LLC | 1 | $17 |
| PFIZER INC. | 1 | $17 |
Products named: Veozah, QULIPTA, UBRELVY, VRAYLAR, REXULTI, Kerendia, SYNTHROID, Korlym.
Industry payments across OH — which companies pay providers there.
